The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.
Identifieur interne : 000121 ( Main/Corpus ); précédent : 000120; suivant : 000122The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.
Auteurs : Shagun B. Shah ; Akhilesh Pahade ; Rajiv ChawlaSource :
- Journal of anaesthesiology, clinical pharmacology [ 0970-9185 ]
Abstract
Background and Aims
HCQ gained importance following the National Task Force advisory as an anti-SARS-Cov-2 (coronavirus disease-2019 [COVID-19]) drug for frontline healthcare workers (including anesthesiologists). Report of a young anesthesiologist in Assam developing cardiac arrest following HCQ intake for COVID-19 prophylaxis made us even more concerned. A conscious decision has been made by a large majority among us--to have or not to have HCQ. However, less severe complications such as gastrointestinal upset, skin-rash, visual-disturbance, headache, and dizziness even if experienced by HCQ users were likely to go unreported unless shared. The present survey was conducted to assess the prevailing perception among Indian anesthesiologists about HCQ's preventive effect against COVID-19. The information has been pooled together and discussed in this study.
Material and Methods
A total of 247 respondents participated in this pan-India survey. The survey questionnaire was prepared using "Google Forms" and conducted via links delivered through WhatsApp and electronic-mail.
Results
55.9% (138/247) of the respondents had consumed HCQ, 38% (94/247) did not, and 6.1% (15/247) were undecided at the time of responding to the survey. In total, 47 respondents who ingested HCQ reported a side-effect, gastritis being the commonest (31).
Conclusion
The evidence for the effectiveness of HCQ against COVID-19 in India is reportedly as strong and weak as other drugs that have been promoted. The survey highlights the reasons consumption of HCQ and represents the opinion of 247 practicing Indian anesthesiologists. It informs the benefits and side effects of HCQ, which can help others in reaching a balanced decision.
DOI: 10.4103/joacp.JOACP_379_20
PubMed: 33840926
PubMed Central: PMC8022063
Links to Exploration step
pubmed:33840926Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.</title><author><name sortKey="Shah, Shagun B" sort="Shah, Shagun B" uniqKey="Shah S" first="Shagun B" last="Shah">Shagun B. Shah</name><affiliation><nlm:affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Pahade, Akhilesh" sort="Pahade, Akhilesh" uniqKey="Pahade A" first="Akhilesh" last="Pahade">Akhilesh Pahade</name><affiliation><nlm:affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Chawla, Rajiv" sort="Chawla, Rajiv" uniqKey="Chawla R" first="Rajiv" last="Chawla">Rajiv Chawla</name><affiliation><nlm:affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Oct-Dec</date><idno type="RBID">pubmed:33840926</idno><idno type="pmid">33840926</idno><idno type="doi">10.4103/joacp.JOACP_379_20</idno><idno type="pmc">PMC8022063</idno><idno type="wicri:Area/Main/Corpus">000121</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000121</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.</title><author><name sortKey="Shah, Shagun B" sort="Shah, Shagun B" uniqKey="Shah S" first="Shagun B" last="Shah">Shagun B. Shah</name><affiliation><nlm:affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Pahade, Akhilesh" sort="Pahade, Akhilesh" uniqKey="Pahade A" first="Akhilesh" last="Pahade">Akhilesh Pahade</name><affiliation><nlm:affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Chawla, Rajiv" sort="Chawla, Rajiv" uniqKey="Chawla R" first="Rajiv" last="Chawla">Rajiv Chawla</name><affiliation><nlm:affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of anaesthesiology, clinical pharmacology</title><idno type="ISSN">0970-9185</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>Background and Aims</b></p><p>HCQ gained importance following the National Task Force advisory as an anti-SARS-Cov-2 (coronavirus disease-2019 [COVID-19]) drug for frontline healthcare workers (including anesthesiologists). Report of a young anesthesiologist in Assam developing cardiac arrest following HCQ intake for COVID-19 prophylaxis made us even more concerned. A conscious decision has been made by a large majority among us--to have or not to have HCQ. However, less severe complications such as gastrointestinal upset, skin-rash, visual-disturbance, headache, and dizziness even if experienced by HCQ users were likely to go unreported unless shared. The present survey was conducted to assess the prevailing perception among Indian anesthesiologists about HCQ's preventive effect against COVID-19. The information has been pooled together and discussed in this study.</p></div><div type="abstract" xml:lang="en"><p><b>Material and Methods</b></p><p>A total of 247 respondents participated in this pan-India survey. The survey questionnaire was prepared using "Google Forms" and conducted via links delivered through WhatsApp and electronic-mail.</p></div><div type="abstract" xml:lang="en"><p><b>Results</b></p><p>55.9% (138/247) of the respondents had consumed HCQ, 38% (94/247) did not, and 6.1% (15/247) were undecided at the time of responding to the survey. In total, 47 respondents who ingested HCQ reported a side-effect, gastritis being the commonest (31).</p></div><div type="abstract" xml:lang="en"><p><b>Conclusion</b></p><p>The evidence for the effectiveness of HCQ against COVID-19 in India is reportedly as strong and weak as other drugs that have been promoted. The survey highlights the reasons consumption of HCQ and represents the opinion of 247 practicing Indian anesthesiologists. It informs the benefits and side effects of HCQ, which can help others in reaching a balanced decision.</p></div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33840926</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0970-9185</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>4</Issue><PubDate><MedlineDate>2020 Oct-Dec</MedlineDate></PubDate></JournalIssue><Title>Journal of anaesthesiology, clinical pharmacology</Title><ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.</ArticleTitle><Pagination><MedlinePgn>471-476</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/joacp.JOACP_379_20</ELocationID><Abstract><AbstractText Label="Background and Aims" NlmCategory="UNASSIGNED">HCQ gained importance following the National Task Force advisory as an anti-SARS-Cov-2 (coronavirus disease-2019 [COVID-19]) drug for frontline healthcare workers (including anesthesiologists). Report of a young anesthesiologist in Assam developing cardiac arrest following HCQ intake for COVID-19 prophylaxis made us even more concerned. A conscious decision has been made by a large majority among us--to have or not to have HCQ. However, less severe complications such as gastrointestinal upset, skin-rash, visual-disturbance, headache, and dizziness even if experienced by HCQ users were likely to go unreported unless shared. The present survey was conducted to assess the prevailing perception among Indian anesthesiologists about HCQ's preventive effect against COVID-19. The information has been pooled together and discussed in this study.</AbstractText><AbstractText Label="Material and Methods" NlmCategory="UNASSIGNED">A total of 247 respondents participated in this pan-India survey. The survey questionnaire was prepared using "Google Forms" and conducted via links delivered through WhatsApp and electronic-mail.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">55.9% (138/247) of the respondents had consumed HCQ, 38% (94/247) did not, and 6.1% (15/247) were undecided at the time of responding to the survey. In total, 47 respondents who ingested HCQ reported a side-effect, gastritis being the commonest (31).</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">The evidence for the effectiveness of HCQ against COVID-19 in India is reportedly as strong and weak as other drugs that have been promoted. The survey highlights the reasons consumption of HCQ and represents the opinion of 247 practicing Indian anesthesiologists. It informs the benefits and side effects of HCQ, which can help others in reaching a balanced decision.</AbstractText><CopyrightInformation>Copyright: © 2020 Journal of Anaesthesiology Clinical Pharmacology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Shagun B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahade</LastName><ForeName>Akhilesh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chawla</LastName><ForeName>Rajiv</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA><NlmUniqueID>9516972</NlmUniqueID><ISSNLinking>0970-9185</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesiologist</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">hydroxychloroquine</Keyword><Keyword MajorTopicYN="N">prophylaxis</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33840926</ArticleId><ArticleId IdType="doi">10.4103/joacp.JOACP_379_20</ArticleId><ArticleId IdType="pii">JOACP-36-471</ArticleId><ArticleId IdType="pmc">PMC8022063</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BJGP Open. 2020 Jun 23;4(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">32265182</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Discov. 2020 Mar 18;6(1):16</Citation><ArticleIdList><ArticleId IdType="pubmed">33731711</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference><Reference><Citation>J Family Med Prim Care. 2020 May 31;9(5):2149-2157</Citation><ArticleIdList><ArticleId IdType="pubmed">32754463</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jun;129(6):643-644</Citation><ArticleIdList><ArticleId IdType="pubmed">32331804</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Syndr. 2020 May - Jun;14(3):241-246</Citation><ArticleIdList><ArticleId IdType="pubmed">32247211</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2020 Jul;87:59-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32334062</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Syndr. 2020 May - Jun;14(3):251-254</Citation><ArticleIdList><ArticleId IdType="pubmed">32247213</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000121 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000121 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:33840926
|texte= The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33840926" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |